Wegovy (semaglutide) is a once-weekly injectable prescription medication specifically licensed in the UK for chronic weight management. It works by mimicking the GLP-1 hormone, which helps regulate appetite and slows gastric emptying so you feel fuller for longer. In clinical trials, patients using semaglutide lost an average of 14-17% of their body weight over around 68 weeks, alongside a reduced-calorie diet and increased physical activity.
Browse our range of Wegovy pen strengths below. Before starting treatment, every patient completes a full clinical assessment with one of our UK-registered prescribers, who will check your medical history and confirm that Wegovy is appropriate and safe for you. Your dose is then introduced gradually and reviewed regularly to help manage side effects and support steady progress.
Our clinical team is available throughout your treatment to answer questions about starting Wegovy, adjusting your dose, and combining medication with sustainable lifestyle changes.
Showing the single result
